Micro-dosing Intravenous Buprenorphine to Rapidly Transition from Full Opioid Agonists

Ashish P. Thakrar, Lindsay Jablonski, Jessica Ratner, Darius A. Rastegar

Research output: Contribution to journalArticlepeer-review

Abstract

For patients with opioid use disorder transitioning from methadone or requiring opioid analgesia, initiating buprenorphine for opioid use disorder can be difficult because of the risk of precipitated withdrawal. Low-dose initiation, also known as micro-dosing, is an alternative to standard initiation. Prior studies relied on nonstandard dosing of tablets or films, patches, or buccal formulations, all of which are unavailable in many hospitals. We report a novel approach to micro-dosing using intravenous buprenorphine. Two patients, one on methadone maintenance and another requiring postoperative opioid analgesia, were transitioned to buprenorphine with concurrent full-agonist opioids and without precipitated withdrawal.

Original languageEnglish (US)
Pages (from-to)122-124
Number of pages3
JournalJournal of addiction medicine
Volume16
Issue number1
DOIs
StatePublished - Jan 1 2022

Keywords

  • buprenorphine
  • inpatients
  • micro-dosing
  • opioids
  • pain

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Micro-dosing Intravenous Buprenorphine to Rapidly Transition from Full Opioid Agonists'. Together they form a unique fingerprint.

Cite this